ID WIL2 NS AC CVCL_2761 SY WIL2-NS; WIL-2NS; WIL-2-NS; WI-L2-NS; WI-L2 NS; WIL2NS; WIL2 Non-Secreting DR BTO; BTO_0001524 DR CLO; CLO_0009601 DR CLO; CLO_0009604 DR CLDB; cl4717 DR ArrayExpress; E-MTAB-3610 DR ATCC; CRL-8155 DR BioSample; SAMN03471196 DR BioSample; SAMN03472416 DR cancercelllines; CVCL_2761 DR Cell_Model_Passport; SIDM01102 DR ChEMBL-Cells; CHEMBL3308012 DR ChEMBL-Targets; CHEMBL612810 DR Cosmic-CLP; 1331049 DR DepMap; ACH-002316 DR ECACC; 90112121 DR EGA; EGAS00001000978 DR FANTOM5_SSTAR; 10808-111A7 DR GDSC; 1331049 DR GEO; GSM827461 DR GEO; GSM1670575 DR GEO; GSM4288411 DR IARC_TP53; 4041 DR IPD-IMGT/HLA; 11561 DR JCRB; JCRB9063 DR PharmacoDB; WIL2NS_1661_2019 DR PRIDE; PXD030304 DR Progenetix; CVCL_2761 DR PubChem_Cell_line; CVCL_2761 DR RCB; RCB2285 DR TKG; TKG 0374 DR Wikidata; Q54994065 RX Patent=US4806476; RX PubMed=1677771; RX PubMed=7798274; RX PubMed=20215515; RX PubMed=27397505; RX PubMed=29892436; RX PubMed=30894373; RX PubMed=33198927; RX PubMed=35839778; CC Group: Hybridoma fusion partner cell line. CC Group: Patented cell line. CC Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). CC Part of: COSMIC cell lines project. CC Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8155. CC Population: Caucasian. CC Characteristics: Does not secrete immunoglobulins. CC HLA typing: DPA1*02:02:02 (IPD-IMGT/HLA=11561). CC Microsatellite instability: Stable (MSS) (Sanger). CC Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (PubMed=33198927). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>A); ClinVar=VCV000142714; Zygosity=Homozygous (PubMed=7798274; PubMed=33198927). CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). CC Omics: Genomics; DNA methylation analysis. CC Omics: Genomics; Whole exome sequencing. CC Omics: Phenotyping; Drug screening. CC Omics: Proteomics; Quantitative. CC Omics: Transcriptomics; Microarray. CC Omics: Variations; SNP array analysis. CC Genome ancestry: African=0%; Native American=0.61%; East Asian, North=0%; East Asian, South=0%; South Asian=1.47%; European, North=69.86%; European, South=28.06% (PubMed=30894373). CC Discontinued: RCB; RCB2285; true. CC Discontinued: TKG; TKG 0374; probable. CC Derived from site: In situ; Spleen; UBERON=UBERON_0002106. CC Cell type: B-cell; CL=CL_0000236. ST Source(s): ATCC=CRL-8155; Cosmic-CLP=1331049; ECACC=90112121; JCRB=JCRB9063; RCB=RCB2285 ST Amelogenin: X,Y ST CSF1PO: 11,12 ST D13S317: 11 ST D16S539: 11,12 ST D18S51: 11,15 ST D19S433: 14,16 ST D21S11: 29 ST D2S1338: 17,25 ST D3S1358: 16 ST D5S818: 12,13 ST D7S820: 9,12 ST D8S1179: 10,13 ST F13A01: 6,7 ST F13B: 10 ST FESFPS: 11,12 ST FGA: 22,24 ST LPL: 9,10 ST Penta D: 11,12 ST Penta E: 5,7 ST TH01: 8,9.3 (ATCC=CRL-8155; Cosmic-CLP=1331049; ECACC=90112121; RCB=RCB2285) ST TH01: 8,10 (JCRB=JCRB9063) ST TPOX: 8,11 ST vWA: 17,20 DI NCIt; C97074; Hereditary spherocytosis DI ORDO; Orphanet_822; Hereditary spherocytosis OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_6544 ! WIL2 SX Male AG 5Y CA Transformed cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 36 CH CVCL_Z045 ! HO-323 CH CVCL_6416 ! LTR228 CH CVCL_2762 ! WIL2.NS.6TG CH CVCL_6742 ! WTK-1 // RX PubMed=7798274; DOI=10.1016/S0021-9258(18)31687-9; RA Carrier, France RA Smith, Martin L. RA Bae, Insoo RA Kilpatrick, Katherine E. RA Lansing, Timothy J. RA Chen, Chaw-Yuan RA Engelstein, Marcy RA Friend, Stephen H. RA Henner, W. David RA Gilmer, Tona Morgan RA Kastan, Michael Barry RA Fornace, Albert J. Jr. RT "Characterization of human Gadd45, a p53-regulated protein."; RL J. Biol. Chem. 269:32672-32677(1994). // RX PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010; PMCID=PMC9387775; RA Goncalves, Emanuel RA Poulos, Rebecca C. RA Cai, Zhao-Xiang RA Barthorpe, Syd RA Manda, Srikanth S. RA Lucas, Natasha RA Beck, Alexandra RA Bucio-Noble, Daniel RA Dausmann, Michael RA Hall, Caitlin RA Hecker, Michael RA Koh, Jennifer RA Lightfoot, Howard RA Mahboob, Sadia RA Mali, Iman RA Morris, James RA Richardson, Laura RA Seneviratne, Akila J. RA Shepherd, Rebecca RA Sykes, Erin RA Thomas, Frances RA Valentini, Sara RA Williams, Steven G. RA Wu, Yang-Xiu RA Xavier, Dylan RA MacKenzie, Karen L. RA Hains, Peter G. RA Tully, Brett RA Robinson, Phillip James RA Zhong, Qing RA Garnett, Mathew J. RA Reddel, Roger Robert RT "Pan-cancer proteomic map of 949 human cell lines."; RL Cancer Cell 40:835-849.e8(2022). // RX PubMed=33198927; DOI=10.1016/j.mrgentox.2020.503236; RA Kasai, Fumio RA Hirayama, Noriko RA Kohara, Arihiro RT "TK6 genome profile compared with WIL2-NS: reference data to improve RT the reproducibility of genotoxicity studies."; RL Mutat. Res. Genet. Toxicol. Environ. Mutagen. 858:503236.1-503236.7(2020). // RX PubMed=27397505; DOI=10.1016/j.cell.2016.06.017; PMCID=PMC4967469; RA Iorio, Francesco RA Knijnenburg, Theo A. RA Vis, Daniel J. RA Bignell, Graham Robert RA Menden, Michael Patrick RA Schubert, Michael RA Aben, Nanne RA Goncalves, Emanuel RA Barthorpe, Syd RA Lightfoot, Howard RA Cokelaer, Thomas RA Greninger, Patricia RA van Dyk, Ewald RA Chang, Han RA de Silva, Heshani RA Heyn, Holger RA Deng, Xian-Ming RA Egan, Regina K. RA Liu, Qing-Song RA Mironenko, Tatiana RA Mitropoulos, Xeni RA Richardson, Laura RA Wang, Jin-Hua RA Zhang, Ting-Hu RA Moran, Sebastian RA Sayols, Sergi RA Soleimani, Maryam RA Tamborero, David RA Lopez-Bigas, Nuria RA Ross-Macdonald, Petra RA Esteller, Manel RA Gray, Nathanael S. RA Haber, Daniel Arie RA Stratton, Michael Rudolf RA Benes, Cyril Henri RA Wessels, Lodewyk F.A. RA Saez-Rodriguez, Julio RA McDermott, Ultan RA Garnett, Mathew J. RT "A landscape of pharmacogenomic interactions in cancer."; RL Cell 166:740-754(2016). // RX PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675; RA Dutil, Julie RA Chen, Zhi-Hua RA Monteiro, Alvaro N.A. RA Teer, Jamie K. RA Eschrich, Steven A. RT "An interactive resource to probe genetic diversity and estimated RT ancestry in cancer cell lines."; RL Cancer Res. 79:1263-1273(2019). // RX PubMed=29892436; DOI=10.1098/rsos.172472; PMCID=PMC5990783; RA Shioda, Setsuko RA Kasai, Fumio RA Watanabe, Ken RA Kawakami, Kohei RA Ohtani, Azusa RA Iemura, Masashi RA Ozawa, Midori RA Arakawa, Akemi RA Hirayama, Noriko RA Kawaguchi, Eiko RA Tano, Tomoko RA Miyata, Sayaka RA Satoh, Motonobu RA Shimizu, Norio RA Kohara, Arihiro RT "Screening for 15 pathogenic viruses in human cell lines registered at RT the JCRB Cell Bank: characterization of in vitro human cells by viral RT infection."; RL R. Soc. Open Sci. 5:172472-172472(2018). // RX PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458; PMCID=PMC2881662; RA Rothenberg, S. Michael RA Mohapatra, Gayatry RA Rivera, Miguel N. RA Winokur, Daniel RA Greninger, Patricia RA Nitta, Mai RA Sadow, Peter M. RA Sooriyakumar, Gaya RA Brannigan, Brian W. RA Ulman, Matthew J. RA Perera, Rushika M. RA Wang, Rui RA Tam, Angela RA Ma, Xiao-Jun RA Erlander, Mark RA Sgroi, Dennis C. RA Rocco, James W. RA Lingen, Mark W. RA Cohen, Ezra E.W. RA Louis, David Neil RA Settleman, Jeffrey RA Haber, Daniel Arie RT "A genome-wide screen for microdeletions reveals disruption of RT polarity complex genes in diverse human cancers."; RL Cancer Res. 70:2158-2164(2010). // RX Patent=US4806476; RA Coons, Teresa RA Avner, Barry RT "Efficient cell fusion process."; RL Patent number US4806476, 21-Feb-1989. // RX PubMed=1677771; DOI=10.1073/pnas.88.15.6652; PMCID=PMC52146; RA Benjamin, Mark B. RA Potter, Huntington RA Yandell, David William RA Little, John Bertram RT "A system for assaying homologous recombination at the endogenous RT human thymidine kinase gene."; RL Proc. Natl. Acad. Sci. U.S.A. 88:6652-6656(1991). //